Catheter Precision
VTAK
7 hedge funds and large institutions have $10.2M invested in Catheter Precision in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
11% more capital invested
Capital invested by funds: $9.19M → $10.2M (+$1.02M)
0% less ownership
Funds ownership: 0% → 0% (-0%)
22% less funds holding
Funds holding: 9 → 7 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
+$911K |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$911K |
| 3 |
RA
Royce & Associates
New York
|
+$911K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$911K |
| 2 |
SCM
Sio Capital Management
New York
|
-$590K |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$456K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$238K |
| 5 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
-$93K |
VTAK Hedge Fund Activity: Q2 2019 in Review
7 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2019, worth a combined $10.2M — up 11% from $9.19M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VTAK and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Alethea Capital Management, adding an estimated $911K. The largest seller was Vanguard Group, exiting entirely with an estimated $911K sold.
- 7 institutional investors held Catheter Precision (VTAK) as of Q2 2019, down from 9 in Q1 2019.
- Funds reported $10.2M of Catheter Precision stock for Q2 2019, up 11% quarter-over-quarter.
- 1 fund opened new Catheter Precision positions in Q2 2019 and 3 closed out, a net change of -2 holders.
- The largest Catheter Precision buyer in Q2 2019 was Alethea Capital Management, an estimated $911K added.
- The largest Catheter Precision seller in Q2 2019 was Vanguard Group, an estimated $911K sold.
Based on aggregated 13F filings for Q2 2019.